Design and antiproliferative and antioxidant activities of furan-based thiosemicarbazides and 1,2,4-triazoles: their structure-activity relationship and SwissADME predictions
作者:Yusuf Sicak
DOI:10.1007/s00044-021-02756-z
日期:2021.8
antiproliferative activity against the cervical (HeLa) cancer cell line among the compounds. In the lipid peroxidation inhibitory activity, thiosemicarbazide derivatives 3, 10, and 9 showed highest activity with IC50 of 21.80 ± 0.69, 26.49 ± 0.61, and 29.07 ± 0.52 µM, respectively, while triazole derivatives 15, 18, 19, 20, 21, and 22 exhibited the highest activity. Moreover, physicochemical properties,
由于目前临床使用的药物数量有限,呋喃的多样化生物应用促进了多种缩氨基硫脲和三唑衍生物的制备,以开发新的药物制剂。本研究旨在探讨氨基硫脲的抗增殖和抗氧化活性(1 - 12)和1,2,4-三唑(13 - 24)。在合成的目标化合物中,3 , 4 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 15 , 16,18,19,20,21,22,23,和24是新的,而其余的化合物的合成中存在的文献中。化合物15 (IC 50 : 8.81 ± 0.28 µM) 在化合物中对宫颈 (HeLa) 癌细胞系显示出最高的抗增殖活性。在脂质过氧化抑制活性中,氨基硫脲衍生物3、10和9表现出最高的活性,IC 50 分别为 21.80 ± 0.69、26.49 ± 0.61 和 29.07 ± 0.52 µM,而三唑衍生物15、18、19、20、21和22表现出最高的活性。此外,使用 SwissADME